Bing

SEARCH HISTORY

Bristol-Myers Squibb’s stock has been on a gradual uptrend, and it is not hard to understand why. In fact, we recently upgraded our own price estimate for BMY to $65 per share. The situation has turned favorable for the company with promising new drugs ...
Forbes · 7/21/2015
Bristol Myers Squibb
Donald Trump disclosed his financials last week, and Americans now know what the Republican presidential hopeful/celebrity mogul holds in his stock portfolios ... Verizon, Wal-Mart, Bristol Myers Squibb, Altria …
Philadelphia Daily News · ByErin E. Arvedlund · 7/27/2015
Trump
Bristol-Myers Squibb Inc.'s stock BMY, -0.46% took an afternoon tumble Friday, to close down 6.6% on heavy volume, as investors expressed disappointment over the drugmaker's updates to studies of its cancer treatment Opdivo. The stock was trading …
Market Watch · ByTomi Kilgore · 5/29/2015
The New York, NY-based hedge fund established a short position on 2.7% of the drugmaker's shares last month, positioning itself to profit if the stock price sinks ... Bavarian Nordic's cancer vaccine with Bristol-Myers' Yervoy, after which it concluded ...
Fierce Biotech · 12 hours ago
Bavarian Nordic
Collaboration revenue earned under Portola's collaborations with Bristol-Myers Squibb Company and Pfizer ... Total operating expenses for the second quarter of 2015 included $4.8 million in stock-based compensation expense compared with $2.4 million ...
Financial Content · 13 hours ago
Bristol-Myersstock fell more than 7% to $64.24 amid concerns about data released today regarding the use of the drug Opdivo in patient suffering from the most common form of lung cancer. It’s an exciting drug class and analysts see sales for ...
Barron's · ByJohanna Bennett · 5/29/2015
SunTrust’s top pharmaceutical stocks to buy for 2015 include Merck & Co. Inc. (NYSE: MRK), Bristol-Myers Squibb Co. (NYSE ... The SunTrust price target for the stock is $80. The Thomson/First Call consensus price target is $63.92. Merck closed …
24/7 Wall ST · 12/29/2014
Your own personalized stock watchlist! It's a 100% FREE Motley Fool service ... After a disappointing run with multiple drugs and rising FDA demands for new drugs, Bristol-Myers Squibb (NYSE: BMY ) and AstraZeneca (NYSE: AZN ) have reached an …
The Motley Fool · 12/21/2013
Pharmaceutical stocks have been on fire for several years now ... Valeant is also seeing strong growth in China, the Middle East, and Russia. Bristol-Myers Squibb Company (BMY) recently hit a 14-year high. Having a seemingly never-ending pipeline and ...
Investopedia · 3/17/2015
Bristol-Myers was 2.7 percent higher at last trade of $65.40. The stock has gained 11 percent this year and 32 percent over the prior 52 weeks. The company is still below its all-time peak around $80 per share hit in 1999.
Benzinga · 4/17/2015
Related Searches

Bristol-Myers Squibb

Company
Bristol-Myers Squibb, often referred to as BMS, is an American pharmaceutical company, headquartered in New York City. Bristol-M…
Bristol-Myers Squibb, often referred to as BMS, is an American pharmaceutical company, headquartered in New York City. Bristol-Myers Squibb manufactures prescription pharmaceuticals in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders. Its mission is to "discover, develop and deliver innovative medicines that help patients prevail over serious diseases."
Data from: Wikipedia · Freebase